Journal article · 2021 · Open access

Anti-Cancer Drug Screening with Microfluidic Technology

Mojdeh Monjezi, Milad Rismanian, Hamidreza Jamaati, Navid Kashaninejad

Applied Sciences, 11(20), 9418 · Published 11 October 2021 · DOI 10.3390/app11209418

Open PDFView at the publisherCite this paper

In brief

“Anti-Cancer Drug Screening with Microfluidic Technology” is a 2021 journal article by Mojdeh Monjezi and 3 co-authors, published in Applied Sciences. OpenAlex counts 30 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Applied Sciences.

Citations
30
Most cited in
2024 (7)
Field-weighted impact
1.16
References
79
Authors
4

Abstract

The up-and-coming microfluidic technology is the most promising platform for designing anti-cancer drugs and new point-of-care diagnostics. Compared to conventional drug screening methods based on Petri dishes and animal studies, drug delivery in microfluidic systems has many advantages. For instance, these platforms offer high-throughput drug screening, require a small number of samples, provide an in vivo-like microenvironment for cells, and eliminate ethical issues associated with animal studies. Multiple cell cultures in microfluidic chips could better mimic the 3D tumor environment using low reagents consumption. The clinical experiments have shown that combinatorial drug treatments have a better therapeutic effect than monodrug therapy. Many attempts have been made in this field in the last decade. This review highlights the applications of microfluidic chips in anti-cancer drug screening and systematically categorizes these systems as a function of sample size and combination of drug screening. Finally, it provides a perspective on the future of the clinical applications of microfluidic systems for anti-cancer drug development.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Monjezi, M., Rismanian, M., Jamaati, H., & Kashaninejad, N. (2021). Anti-Cancer Drug Screening with Microfluidic Technology. Applied Sciences, 11(20), 9418. https://doi.org/10.3390/app11209418

MLA 9

Monjezi, Mojdeh, et al. “Anti-Cancer Drug Screening with Microfluidic Technology.” Applied Sciences, vol. 11, no. 20, 2021, p. 9418. https://doi.org/10.3390/app11209418.

Chicago

Monjezi, Mojdeh, Milad Rismanian, Hamidreza Jamaati, and Navid Kashaninejad. 2021. “Anti-Cancer Drug Screening with Microfluidic Technology.” Applied Sciences 11 (20): 9418. https://doi.org/10.3390/app11209418.

Harvard

Monjezi, M. et al. (2021) ‘Anti-Cancer Drug Screening with Microfluidic Technology’, Applied Sciences, 11(20), p. 9418. doi:10.3390/app11209418.

IEEE

M. Monjezi, M. Rismanian, H. Jamaati, and N. Kashaninejad, “Anti-Cancer Drug Screening with Microfluidic Technology,” Applied Sciences, vol. 11, no. 20, p. 9418, 2021, doi: 10.3390/app11209418.

BibTeX

@article{monjezi2021anti,
  title     = {{Anti-Cancer Drug Screening with Microfluidic Technology}},
  author    = {Monjezi, Mojdeh and Rismanian, Milad and Jamaati, Hamidreza and Kashaninejad, Navid},
  journal   = {Applied Sciences},
  year      = {2021},
  volume    = {11},
  number    = {20},
  pages     = {9418},
  doi       = {10.3390/app11209418},
  url       = {https://doi.org/10.3390/app11209418}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202111
202244
202366
202477
202555
202677

Its field-weighted citation impact is 1.16: it has been cited 1.16 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications

  • microfluidics
  • anticancer drug screening
  • high-throughput drug screening
  • 3D tumor models
  • combination therapy
  • point-of-care testing
  • alternatives to animal testing

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Monjezi, M., Rismanian, M., Jamaati, H., & Kashaninejad, N. (2021). Anti-Cancer Drug Screening with Microfluidic Technology. Applied Sciences, 11(20), 9418. https://doi.org/10.3390/app11209418

How many times has this paper been cited?

30 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Applied Sciences: sign in and open the PDF from this page.

Who wrote this paper?

Mojdeh Monjezi, Milad Rismanian, Hamidreza Jamaati, Navid Kashaninejad.

What is the DOI of this paper?

10.3390/app11209418, permanently at https://doi.org/10.3390/app11209418. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.